Prognostic Factors of Survival After Radiotherapy for Lung Cancer–The Impact of Smoking Pack Years

ELISA M. WERNER; ESTHER GLATZEL; SABINE BOHNET; STEVEN E. SCHILD; DIRK RADES

doi:10.21873/invivo.12830

Article Information

vol. 36 no. 3 1297-1301

DOI

https://doi.org/10.21873/invivo.12830

PubMed

35478154

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received February 18, 2022
Revision received February 28, 2022
Accepted March 1, 2022
Published online April 27, 2022.

Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

ELISA M. WERNER¹,
ESTHER GLATZEL¹,
SABINE BOHNET²,
STEVEN E. SCHILD³ and
DIRK RADES¹

¹Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
²Department of Pulmonology, University of Lübeck, Lübeck, Germany;
³Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.

Correspondence to: Prof. Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany. Tel: +49 45150045401, Fax: +49 45150045404, e-mail: dirk.rades{at}uksh.de

View Full Text